Jia Ruan, MD, PhD | Authors


Azacitadine Demonstrates Efficacy in a Phase 2 Trial of PTCL

December 18, 2020

Jia Ruan, MD, PhD, discusses the results of the multicenter phase 2 trial of oral azacitidine plus cyclophosphamide, doxorubicin, vincristine, and prednisone as initial treatment in patients with peripheral T-cell lymphoma.